Articles with "secondary sclerosing" as a keyword



Photo by matmacq from unsplash

Antiprogrammed Cell Death‐1 Immunotherapy‐Related Secondary Sclerosing Cholangitis

Sign Up to like & get
recommendations!
Published in 2019 at "Hepatology"

DOI: 10.1002/hep.30189

Abstract: Secondary sclerosing cholangitis (SSC) is a rare disease that is associated with various etiologies. Recent development of immune checkpoint inhibitors demonstrates efficacy in the treatment of various malignancies; however, these inhibitors can also cause immune-related… read more here.

Keywords: antiprogrammed cell; cell death; secondary sclerosing; sclerosing cholangitis ... See more keywords
Photo from wikipedia

Case report: Secondary sclerosing cholangitis induced by lapatinib and vinorelbine in a metastasis breast cancer patient

Sign Up to like & get
recommendations!
Published in 2021 at "Thoracic Cancer"

DOI: 10.1111/1759-7714.13986

Abstract: Secondary sclerosing cholangitis (SSC) is a rare cholestatic liver disease that may have a severe clinical course. A 61‐year‐old woman with a history of metastasis breast cancer was admitted to our hospital for the second… read more here.

Keywords: lapatinib vinorelbine; case; cancer; secondary sclerosing ... See more keywords
Photo from wikipedia

Effect of endoscopic treatment in patients with secondary sclerosing cholangitis

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Gastroenterology and Hepatology"

DOI: 10.1111/jgh.15977

Abstract: Secondary sclerosing cholangitis (SSC) is a progressive disease with high mortality and characterized by chronic inflammation and biliary obstruction. Therapeutic options are limited. The aim of this retrospective study was to evaluate the effects of… read more here.

Keywords: endoscopic treatment; sclerosing cholangitis; secondary sclerosing; treatment patients ... See more keywords
Photo from wikipedia

Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection

Sign Up to like & get
recommendations!
Published in 2020 at "BMJ Case Reports"

DOI: 10.1136/bcr-2020-237984

Abstract: A previously well 59-year-old man required a prolonged intensive care unit stay due to severe COVID-19 symptoms. During the admission, he developed a cytokine storm, also known as secondary haemophagocytic lymphohistocytosis, and multiorgan failure. Despite… read more here.

Keywords: cholangitis critically; rare disease; disease; critically ill ... See more keywords
Photo from wikipedia

Secondary Sclerosing Cholangitis due to Severe COVID-19: An Emerging Disease Entity?

Sign Up to like & get
recommendations!
Published in 2023 at "Digestion"

DOI: 10.1159/000528689

Abstract: Introduction Coronavirus disease 2019 (COVID-19) can lead to many extrapulmonary manifestations. In this case series, we report on 7 patients developing secondary sclerosing cholangitis (SSC) after severe COVID-19 with intensive care treatment. Methods Between March… read more here.

Keywords: secondary sclerosing; covid group; severe covid; sclerosing cholangitis ... See more keywords
Photo from wikipedia

Secondary sclerosing cholangitis in critically ill patients: current perspectives

Sign Up to like & get
recommendations!
Published in 2017 at "Clinical and Experimental Gastroenterology"

DOI: 10.2147/ceg.s115518

Abstract: Secondary sclerosing cholangitis (SSC) is a term used for a group of chronic cholestatic disease affecting the intra- and/or extrahepatic biliary tree with inflammation and progressive stricture formation, which can lead to biliary cirrhosis. A… read more here.

Keywords: cholangitis critically; ill patients; critically ill; secondary sclerosing ... See more keywords
Photo by finnnyc from unsplash

Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19

Sign Up to like & get
recommendations!
Published in 2021 at "Biomedicines"

DOI: 10.3390/biomedicines9121841

Abstract: In critically ill patients, liver dysfunction often results in coagulopathy and encephalopathy and is associated with high mortality. Extracorporeal clearance of hepatotoxic metabolites, including bilirubin and ammonia, aims to attenuate further hepatocyte damage and liver… read more here.

Keywords: ecmo therapy; therapy; bilirubin ammonia; therapy severe ... See more keywords